1. Aaronson S.A. 1991. Growth factors and cancer, Science 254: 1146.
2. Alexander D.B., Goya L., Webster M.K., Haraguchi T. and Firestone G.L. 1993. Glucocorticoids coordinately disrupt a transforming growth factor alpha autocrine loop and suppress the growth of 13762NF-derived Con8 rat mammary adenocarcinoma cells, Cancer Research 53: 1816.
3. Barres B.A., Raff M.C., Gaese F., Bartke I., Dechant G. and Barde Y.-A. 1994. A crucial role for neurotrophin-3 in oligodendrocyte development. Nature 367: 371–375.
4. Bazan J.F. 1989. A novel family of growth factor receptors: a common binding domain in the growth hormone, prolactin, erythropoietin and IL-6 receptors, and the p75 IL-2 receptor beta-chain, Biochem. Biophys. Res. Commun. 164: 788.
5. Berns E.M., Schuurmans A.L., Bolt J., Lamb D.J., Foekens J.A. and Mulder E. 1990. Antiproliferative effects of suramin on androgen responsive tumour cells, Fur. J. Cancer 26: 470.